Related Experiment Video
Updated: Jun 24, 2026
A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
Published on: November 28, 2025
[Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications]
Priscilla Lamendola1, Antonio Di Monaco, Lucy Barone
1Istituto di Cardiologia, Università Cattolica del Sacro Cuore, Roma
Insights
Cardiomyocytes possess protective mechanisms against ischemia-reperfusion injury. This review explores these mechanisms and their therapeutic potential for reducing myocardial cell damage and improving survival.
Area of Science:
- Cardiology
- Cellular Biology
- Biomedical Science
Background:
- Myocardial ischemia causes cell damage through factors like ischemia duration and collateral flow.
- Reperfusion injury, occurring during blood flow restoration, also contributes to myocardial cell damage.
- Cardiomyocytes have endogenous protective mechanisms against ischemia-reperfusion injury.
Purpose of the Study:
- To review endogenous protective mechanisms in cardiomyocytes against ischemia-reperfusion injury.
- To discuss the therapeutic applications of these protective mechanisms in clinical settings.
- To explore interventions for reducing myocardial oxygen demand and optimizing energy utilization during ischemia.
Main Methods:
- Review of scientific literature on myocardial ischemia-reperfusion.
- Analysis of cellular protective mechanisms in cardiomyocytes.
- Discussion of therapeutic strategies including preconditioning, postconditioning, and apoptosis prevention.
Main Results:
- Cardiomyocytes exhibit several protective mechanisms against ischemia-reperfusion damage.
- Ischemic preconditioning (early and delayed) and postconditioning enhance cell survival.
- Interventions targeting oxygen demand and energy optimization show therapeutic promise.
Conclusions:
- Understanding cardiomyocyte protective mechanisms is crucial for treating ischemia-reperfusion injury.
- Therapeutic strategies like preconditioning and postconditioning offer potential clinical benefits.
- Further research into preventing apoptosis may yield novel treatments for myocardial damage.
Abstract:
Myocardial cell damage caused by myocardial ischemia results from several factors that include the duration of ischemia, oxygen demand by cardiomyocytes at the time of ischemia, and the presence and entity of collateral blood flow to the ischemic area. Importantly, myocardial cell injury may derive not only from ischemia itself but also from detrimental phenomena occurring during the restoration of myocardial blood flow after the ischemic episode (reperfusion damage). In the last decades a lot of studies have demonstrated that cardiomyocytes have several mechanisms that provide them protection against the damage deriving from ischemia-reperfusion, also allowing a prolongation of survival in the most severe cases. In this article we review some of these mechanisms, also discussing their present and/or potential therapeutic applications in the clinical setting. The topics include the interventions aimed at reducing cardiac work through a reduction of oxygen demand by myocardial cells or at optimizing the utilization of energetic resources by myocardial cells in situations of ischemia, the importance of phenomena such as ischemic preconditioning (early and delayed) and postconditioning of myocardial cells, and, finally, the theoretic possibility of interventions aimed at preventing cell death consequent to apoptosis.
Related Concept Videos
01:21Myocarditis I: Introduction
01:00Cellular Injury I: Introduction
01:21Cellular Injury II: Classification